Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784674 · ClinicalTrials.gov registry record
Maternal Abdominal Morphology Assessment
A clinical trial of Diabetes and Pregnancy Related, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- 87
- Enrollment target
- 1
- Study location
NCT06784674: Recruiting study of Diabetes and Pregnancy Related, sponsored by University of Texas at Austin.
NCT06784674 is a study of Diabetes and Pregnancy Related that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 87 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784674, a study of Diabetes and Pregnancy Related, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes. The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.
Primary Outcome
Maternal pancreatic volume will be measured at each study visit. MRI will be utilized to determine maternal pancreatic volume in cm\^3.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Texas
- Dell Medical School Health Discovery Building - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2025-05-06 |
| Est. Completion | 2031-12 |
What NCT06784674 shows while recruiting
NCT06784674 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06784674 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06784674 about?
NCT06784674 is a clinical study titled "Maternal Abdominal Morphology Assessment". Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy,...
What is the current status of trial NCT06784674?
This trial is currently recruiting. The enrollment target is 87 participants. The study started on 2025-05-06. Estimated completion is 2031-12.
What conditions does trial NCT06784674 study?
This clinical trial studies the following conditions: Diabetes, Pregnancy Related, Infant Development, Pancreas.
What interventions are being tested in trial NCT06784674?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06784674?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784674 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06784674's enrollment target sits among peer trials
87 207th of 338 higher than 131 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI